Глава 1. Мозг и сон

1. Bielak A. A., Hughes T. F., Small B. J., Dixon R. A. (2007) It’s never too late to engage in lifestyle activities: significant concurrent but not change relationships between lifestyle activities and cognitive speed // Gerontol B Psychol Sci Soc Sci Nov; 62 (6): P331–339.

2. Lydic R., McCarley R. W., Hobson J. A. (1984) Forced activity alters sleep cycle periodicity and dorsal raphe discharge rhythm. Am J. Physiol 247 (1 Pt 2): R135–145. Stanford Report, “Remediation training improves reading ability of dyslexic children,” February 25, 2003 (http://news-service.stanford.edu/news/2003/february26/dyslexia-226.html).

3. McDaniel M. A. (2003) Brain-specific nutrients: a memory cure // Nutrition 11–12: 957–975.

4. Bower, B. (1998) To dream, perchance to scan // Science News 153: 44.

Глава 2. Как поддержать работу сердца…

1. Liem A. H., Jukema J. W., van Veldhuisen D. J. (2003) Secondary prevention in coronary heart disease patients with low HDL: What options do we have? // Int J. Cardiol 90 (1): 15–21.

2. National Center for Health Statistics, “Deaths – leading causes,” cdc.gov/nchs/FASTATS/lcod.htm.

3. Lagergvist B., James S., Stenestrand U., Lindback M., Nilsson T., Wallentin L. (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden // NEJM 356 (10): 1009–1019.

4. Enos W. F, Holmes R. H, Beyer J (1953) Coronary disease among United States soldiers killed in action in Korea // JAMA 152: 1090–1093.

5. The Society for Women’s Health Research, “What really claims women’s lives?” womenshealthresearch.org/site/PageServer?pagename=hs_whatclaims.

6. Becker D., Gordon R., Morris P., Yorko J., Gordon J., Li M., Iqbal N. (2008) Simvastatin vs therapeutic lifestyle changes and supplements: Randomized primary prevention trail // Mayo Clin Proc 83: 758–764.

7. Lu Z., Kou W., Du B., Wu Y., Zhao S., Brusco O., Morgan J., Capuzzi D. (2008) Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction // Amer J. of Card 12 (101): 1689–1693.

8. Gouni-Berthold J., Berthold H. (2002) Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent // Amer Heart J. 143 (2): 356–365.

9. Morike E. M. (1996) Vitamin E treatment of patients with coronary disease // Deutsch Med Wochenschr May, 121 (21): A9.

10. Brook J. G., Linn S., Aviram M. (1986) Phosphatidlylinositol raises HDL cholesterol levels in humans // Biochem Med Metabol Biol (35): 31–39.

11. Katsuyuki M., Daviglus M. L., Dyer A. R., Kiang L., Garside D. B., Stamler J., Greenland P. (2001) Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: The Chicago Heart Association detection project in industry // Arch Intern Med 161: 1501–1509.

12. Bolotin H. H. (2007) DXA in vivo BMD methodology: An erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling // Bone 41 (1): 138–154.